Larazotide is formulated to act locally in the gut lumen with minimal systemic absorption, which simplifies some aspects of CMC and safety, but also limits its reach to the GI tract
Both peptides are referenced in scientific literature for their involvement in cellular signaling, structural protein interaction, and coordinated tissue response pathways in preclinical research
It replicates a 15-amino-acid fragment of the BPC protein naturally present in human gastric juice
This equates to approximately 0.73mcg/lb, or about 146mcg for an individual weighing 200lb
Jeibmann, A., Alves, M., Rago, V., et al
Who It Is For First-time peptide therapy patients looking for a proven, well-tolerated starting point Adults over 35 experiencing declining energy, poor sleep, slower recovery, or gradual body composition changes Patients who want to optimize growth hormone naturally without exogenous GH Athletes seeking improved recovery and training adaptation Anyone building a foundation before adding more targeted peptides What to Expect Weeks 1-2: Improved sleep quality is typically the first noticeable change
